Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008

Although RFS and OS favored CRT, the addition of cisplatin during RT did not statistically improve RFS or OS in cervical cancer patients with intermediate pathological risk factors following radical hysterectomy and lymphadenectomy. CRT increased grade 3 and 4 AEs with a transient decline in QoL.

Authors

Institutions

Publication Details

Journal
Annals of Oncology
Published
2025-09-13
DOI
https://doi.org/10.1016/j.annonc.2025.09.003
Citations
8
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
16.46
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008

Charles A. Leath, Bradley J. Monk, Kevin Albuquerque, C-H Cho et al.
8 citations
Annals of Oncology
Endometrial and Cervical Cancer Treatments
16.46
article

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008

Charles A. Leath, Bradley J. Monk, Kevin Albuquerque, C-H Cho, Dana M. Chase, Jae Hong No, A. Heugel, William H. Rodgers, Kathryn Miller, Jyoti Mayadev, Dorottya Fabian, Robert S. Mannel, Wei Deng, Do Young ‍Kim, Sang Young Ryu, W-J Koh, BJ Kim, JW Kim, Karen M. Gil, William Small
article en
8 citations

Abstract

Although RFS and OS favored CRT, the addition of cisplatin during RT did not statistically improve RFS or OS in cervical cancer patients with intermediate pathological risk factors following radical hysterectomy and lymphadenectomy. CRT increased grade 3 and 4 AEs with a transient decline in QoL.

Annals of OncologyVol. 36(12)
Roswell Park Comprehensive Cancer Center (US), University of California, Los Angeles (US), Loyola University Chicago (US), Cornell University (US), Oklahoma City University (US), University Hospitals of Cleveland (US), Asan Medical Center (KR), Markey Cancer Center (US), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), University of Alabama at Birmingham (US), University of California San Diego (US), Korea Institute of Radiological and Medical Sciences (KR), Florida Cancer Specialists & Research Institute (US), Keimyung University Dongsan Medical Center (KR), Women & Infants Hospital of Rhode Island (US), National Comprehensive Cancer Network, Keimyung University (KR), The University of Texas Southwestern Medical Center (US), University of Oklahoma (US), Northeast Ohio Medical University (US)
Openalex Percentile: Top 1%
Endometrial and Cervical Cancer Treatments
16.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.